List of Tables
Table 1. Rheumatology Drugs Market Trends
Table 2. Rheumatology Drugs Market Drivers & Opportunity
Table 3. Rheumatology Drugs Market Challenges
Table 4. Rheumatology Drugs Market Restraints
Table 5. Global Rheumatology Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Rheumatology Drugs Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Rheumatology Drugs Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Rheumatology Drugs Product Type
Table 9. Key Companies Time to Begin Mass Production of Rheumatology Drugs
Table 10. Global Rheumatology Drugs Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatology Drugs as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Rheumatology Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Rheumatology Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Rheumatology Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Rheumatology Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Rheumatology Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Rheumatology Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Rheumatology Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Rheumatology Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Rheumatology Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Rheumatology Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Rheumatology Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Rheumatology Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Rheumatology Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Rheumatology Drugs Sales Value by Region (2019-2024) & (%)
Table 27. Global Rheumatology Drugs Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Rheumatology Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Rheumatology Drugs Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Rheumatology Drugs Sales Value, (2025-2030) & (US$ Million)
Table 31. Takeda Pharmaceutical Basic Information List
Table 32. Takeda Pharmaceutical Description and Business Overview
Table 33. Takeda Pharmaceutical Rheumatology Drugs Products, Services and Solutions
Table 34. Revenue (US$ Million) in Rheumatology Drugs Business of Takeda Pharmaceutical (2019-2024)
Table 35. Takeda Pharmaceutical Recent Developments
Table 36. Sanofi Basic Information List
Table 37. Sanofi Description and Business Overview
Table 38. Sanofi Rheumatology Drugs Products, Services and Solutions
Table 39. Revenue (US$ Million) in Rheumatology Drugs Business of Sanofi (2019-2024)
Table 40. Sanofi Recent Developments
Table 41. Genentech Basic Information List
Table 42. Genentech Description and Business Overview
Table 43. Genentech Rheumatology Drugs Products, Services and Solutions
Table 44. Revenue (US$ Million) in Rheumatology Drugs Business of Genentech (2019-2024)
Table 45. Genentech Recent Developments
Table 46. Novartis Basic Information List
Table 47. Novartis Description and Business Overview
Table 48. Novartis Rheumatology Drugs Products, Services and Solutions
Table 49. Revenue (US$ Million) in Rheumatology Drugs Business of Novartis (2019-2024)
Table 50. Novartis Recent Developments
Table 51. Janssen Biotech Basic Information List
Table 52. Janssen Biotech Description and Business Overview
Table 53. Janssen Biotech Rheumatology Drugs Products, Services and Solutions
Table 54. Revenue (US$ Million) in Rheumatology Drugs Business of Janssen Biotech (2019-2024)
Table 55. Janssen Biotech Recent Developments
Table 56. Amgen Basic Information List
Table 57. Amgen Description and Business Overview
Table 58. Amgen Rheumatology Drugs Products, Services and Solutions
Table 59. Revenue (US$ Million) in Rheumatology Drugs Business of Amgen (2019-2024)
Table 60. Amgen Recent Developments
Table 61. AbbVie Basic Information List
Table 62. AbbVie Description and Business Overview
Table 63. AbbVie Rheumatology Drugs Products, Services and Solutions
Table 64. Revenue (US$ Million) in Rheumatology Drugs Business of AbbVie (2019-2024)
Table 65. AbbVie Recent Developments
Table 66. Pfizer Basic Information List
Table 67. Pfizer Description and Business Overview
Table 68. Pfizer Rheumatology Drugs Products, Services and Solutions
Table 69. Revenue (US$ Million) in Rheumatology Drugs Business of Pfizer (2019-2024)
Table 70. Pfizer Recent Developments
Table 71. Bristol-Myers Squibb Company Basic Information List
Table 72. Bristol-Myers Squibb Company Description and Business Overview
Table 73. Bristol-Myers Squibb Company Rheumatology Drugs Products, Services and Solutions
Table 74. Revenue (US$ Million) in Rheumatology Drugs Business of Bristol-Myers Squibb Company (2019-2024)
Table 75. Bristol-Myers Squibb Company Recent Developments
Table 76. Merck & Co. Basic Information List
Table 77. Merck & Co. Description and Business Overview
Table 78. Merck & Co. Rheumatology Drugs Products, Services and Solutions
Table 79. Revenue (US$ Million) in Rheumatology Drugs Business of Merck & Co. (2019-2024)
Table 80. Merck & Co. Recent Developments
Table 81. Key Raw Materials Lists
Table 82. Raw Materials Key Suppliers Lists
Table 83. Rheumatology Drugs Downstream Customers
Table 84. Rheumatology Drugs Distributors List
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Rheumatology Drugs Product Picture
Figure 2. Global Rheumatology Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Rheumatology Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Rheumatology Drugs Report Years Considered
Figure 5. Global Rheumatology Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Rheumatology Drugs Revenue in 2023
Figure 7. Rheumatology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Disease Modifying Anti-rheumatic Drugs Picture
Figure 9. Nonsteroidal Anti-inflammatory Drugs Picture
Figure 10. Corticosteroids Picture
Figure 11. Uric Acid Drugs Picture
Figure 12. Others Picture
Figure 13. Global Rheumatology Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Rheumatology Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 15. Product Picture of Hospital Pharmacy
Figure 16. Product Picture of Retail Pharmacy
Figure 17. Product Picture of Online Pharmacy
Figure 18. Global Rheumatology Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Rheumatology Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 20. North America Rheumatology Drugs Sales Value (2019-2030) & (US$ Million)
Figure 21. North America Rheumatology Drugs Sales Value by Country (%), 2023 VS 2030
Figure 22. Europe Rheumatology Drugs Sales Value (2019-2030) & (US$ Million)
Figure 23. Europe Rheumatology Drugs Sales Value by Country (%), 2023 VS 2030
Figure 24. Asia Pacific Rheumatology Drugs Sales Value (2019-2030) & (US$ Million)
Figure 25. Asia Pacific Rheumatology Drugs Sales Value by Country (%), 2023 VS 2030
Figure 26. South America Rheumatology Drugs Sales Value (2019-2030) & (US$ Million)
Figure 27. South America Rheumatology Drugs Sales Value by Country (%), 2023 VS 2030
Figure 28. Middle East & Africa Rheumatology Drugs Sales Value (2019-2030) & (US$ Million)
Figure 29. Middle East & Africa Rheumatology Drugs Sales Value by Country (%), 2023 VS 2030
Figure 30. Key Countries/Regions Rheumatology Drugs Sales Value (%), (2019-2030)
Figure 31. United States Rheumatology Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 32. United States Rheumatology Drugs Sales Value by Type (%), 2023 VS 2030
Figure 33. United States Rheumatology Drugs Sales Value by Application (%), 2023 VS 2030
Figure 34. Europe Rheumatology Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 35. Europe Rheumatology Drugs Sales Value by Type (%), 2023 VS 2030
Figure 36. Europe Rheumatology Drugs Sales Value by Application (%), 2023 VS 2030
Figure 37. China Rheumatology Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 38. China Rheumatology Drugs Sales Value by Type (%), 2023 VS 2030
Figure 39. China Rheumatology Drugs Sales Value by Application (%), 2023 VS 2030
Figure 40. Japan Rheumatology Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 41. Japan Rheumatology Drugs Sales Value by Type (%), 2023 VS 2030
Figure 42. Japan Rheumatology Drugs Sales Value by Application (%), 2023 VS 2030
Figure 43. South Korea Rheumatology Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 44. South Korea Rheumatology Drugs Sales Value by Type (%), 2023 VS 2030
Figure 45. South Korea Rheumatology Drugs Sales Value by Application (%), 2023 VS 2030
Figure 46. Southeast Asia Rheumatology Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 47. Southeast Asia Rheumatology Drugs Sales Value by Type (%), 2023 VS 2030
Figure 48. Southeast Asia Rheumatology Drugs Sales Value by Application (%), 2023 VS 2030
Figure 49. India Rheumatology Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 50. India Rheumatology Drugs Sales Value by Type (%), 2023 VS 2030
Figure 51. India Rheumatology Drugs Sales Value by Application (%), 2023 VS 2030
Figure 52. Rheumatology Drugs Industrial Chain
Figure 53. Rheumatology Drugs Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
